Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Dan Ives from Wedbush Securities joins ‘Closing Bell’ to discuss ride-sharing companies Lyft and Uber. 02:42 Tue, May 3 20224:19 PM EDT Source link

Even with vaccine skeptic Robert F. Kennedy Jr. tapped to potentially lead the Department of Health and Human Services, CNBC’s Jim Cramer said drug and junk food industries aren’t necessarily headed for ruin. “Ultimately, if RFK dons jackboots and demands that we don’t have vaccines or eat junk food, it probably won’t matter,” he said….

‘Mad Money’ host Jim Cramer talks the impact of value conscious consumers on companies. Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Street Signs Europe Evan Brown, portfolio manager and head of multi-asset strategy at UBS, discusses the implications of Trump’s re-election on markets. 03:14 18 minutes ago Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Frederic Mishkin, Columbia University economics professor and former Fed governor, joins CNBC’s ‘Closing Bell’ to discuss expectations for next week’s economic data, reactions to the Fed’s decision to cut rates by a quarter point, and more. 06:25 Fri, Nov 8 20243:49 PM…

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Nelson Peltz, founding partner and CEO at Trian Partners, joins CNBC’s Delivering Alpha 2024 to discuss Trian’s proxy battle with Disney and CEO Bob Iger, his outlook on the consumer and the economy, his vision for the next four years post-presidential election,…